Author:
Murti Krisna,Fender Hendrik,Glatzle Carolin,Wismer Rhoda,Sampere-Birlanga Salvador,Wild Vanessa,Muhammad Khalid,Rosenwald Andreas,Serfling Edgar,Avots Andris
Abstract
In Burkitt lymphoma (BL), a tumor of germinal center B cells, the pro-apoptotic properties of MYC are controlled by tonic B cell receptor (BCR) signals. Since BL cells do not exhibit constitutive NF-κB activity, we hypothesized that anti-apoptotic NFATc1 proteins provide a major transcriptional survival signal in BL. Here we show that post-transcriptional mechanisms are responsible for the calcineurin (CN) independent constitutive nuclear over-expression of NFATc1 in BL and Eµ-MYC – induced B cell lymphomas (BCL). Conditional inactivation of the Nfatc1 gene in B cells of Eµ-MYC mice leads to apoptosis of BCL cells in vivo and ex vivo. Inhibition of BCR/SYK/BTK/PI3K signals in BL cells results in cytosolic re-location of NFATc1 and apoptosis. Therefore, NFATc1 activity is an integrated part of tonic BCR signaling and an alternative target for therapeutic intervention in BL.
Reference47 articles.
1. Strategies to target the cancer driver MYC in tumor cells;Weber;Front Oncol,2023
2. MYC as a target for cancer treatment;Duffy;Cancer Treat Rev,2021
3. Burkitt lymphoma;Lopez;Nat Rev Dis Primers,2022
4. Burkitt's lymphoma;Roschewski;N Engl J Med,2022
5. MYC and the control of apoptosis;McMahon;Cold Spring Harb Perspect Med,2014